Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2008 4
2009 3
2010 2
2011 1
2012 1
2013 1
2014 2
2015 4
2016 7
2017 5
2018 7
2019 6
2020 7
2021 6
2022 7
2023 5
2024 4
2025 11
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.
Sahin U, Oehm P, Derhovanessian E, Jabulowsky RA, Vormehr M, Gold M, Maurus D, Schwarck-Kokarakis D, Kuhn AN, Omokoko T, Kranz LM, Diken M, Kreiter S, Haas H, Attig S, Rae R, Cuk K, Kemmer-Brück A, Breitkreuz A, Tolliver C, Caspar J, Quinkhardt J, Hebich L, Stein M, Hohberger A, Vogler I, Liebig I, Renken S, Sikorski J, Leierer M, Müller V, Mitzel-Rink H, Miederer M, Huber C, Grabbe S, Utikal J, Pinter A, Kaufmann R, Hassel JC, Loquai C, Türeci Ö. Sahin U, et al. Among authors: miederer m. Nature. 2020 Sep;585(7823):107-112. doi: 10.1038/s41586-020-2537-9. Epub 2020 Jul 29. Nature. 2020. PMID: 32728218 Clinical Trial.
Dosimetry of [177Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial.
Bodei L, Cremonesi M, Ferrari M, Mittra ES, Kulkarni HR, Deroose CM, Srirajaskanthan R, Ramage J, Grana CM, Botta F, Weber MM, Miederer M, Reddy R, Chicco D, Mariani MF, Demange A, Erion JL, Gericke G, Krenning E. Bodei L, et al. Among authors: miederer m. J Nucl Med. 2025 Mar 3;66(3):449-456. doi: 10.2967/jnumed.124.268903. J Nucl Med. 2025. PMID: 39947918 Free PMC article. Clinical Trial.
New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study.
Karpinski MJ, Civan C, Rauscher I, Güven O, Eiber M, Hoberück S, Miederer M, Bundschuh RA, Hölscher T, Calais J, Theus L, Nguyen AT, Scholtissek H, Lapa C, Di Giorgio A, Farolfi A, Ufton D, Drzezga A, Kunikowska J, Pełka K, Evangelista L, Bauman G, Alçın G, Beintner-Skawran S, Rohani MFM, Miksch J, Hüsing A, Kesch C, Herrmann K, Stuschke M, Umutlu L, Gafita A, Hofman MS, Hope TA, Goffin K, Kind F, Pizzuto DA, Soeterik TFW, Kömek H, Emmett L, Vondrak A, Pinter T, Lanfranchi F, Bauckneht M, Unterrainer LM, Holzgreve A, Bjartell A, Trägårdh E, Rasul S, Miszczyk M, Bögemann M, Rodriguez SantAnna Jauregui N, Schäfers M, Rahbar K, Hadaschik BA, Fendler WP; PROMISE Registry Group. Karpinski MJ, et al. Among authors: miederer m. Lancet Oncol. 2026 Apr;27(4):480-490. doi: 10.1016/S1470-2045(26)00016-1. Epub 2026 Mar 9. Lancet Oncol. 2026. PMID: 41819113 Free article.
[68Ga]Ga-PSMA-11 PET Tumor Volume Predicts Overall Survival of Patients with Metastatic Prostate Cancer Undergoing Taxane-Based Chemotherapy.
Beintner-Skawran S, Gafita A, Lorenzini T, Tauber R, Hoberück S, Mattana F, Di Giorgio A, Miederer M, Paller CJ, Djaileb L, Solnes LB, Farolfi A, Ceci F, Eiber M, Voter AF. Beintner-Skawran S, et al. Among authors: miederer m. J Nucl Med. 2025 Nov 3;66(11):1743-1749. doi: 10.2967/jnumed.125.269584. J Nucl Med. 2025. PMID: 40935613
Alpha-Emitting Radionuclides: Current Status and Future Perspectives.
Miederer M, Benešová-Schäfer M, Mamat C, Kästner D, Pretze M, Michler E, Brogsitter C, Kotzerke J, Kopka K, Scheinberg DA, McDevitt MR. Miederer M, et al. Pharmaceuticals (Basel). 2024 Jan 8;17(1):76. doi: 10.3390/ph17010076. Pharmaceuticals (Basel). 2024. PMID: 38256909 Free PMC article. Review.
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study.
Karpinski MJ, Rahbar K, Bögemann M, Nikoukar LR, Schäfers M, Hoberück S, Miederer M, Hölscher T, Rasul S, Miszczyk M, Lanfranchi F, Bauckneht M, Pfob CH, Kind F, Goffin K, Hüsing A, Kesch C, Herrmann K, Stuschke M, Gafita A, Hüsing J, Calais J, Hofman MS, Hope TA, Miksch J, Soeterik TFW, Di Giorgio A, Farolfi A, Bjartell A, Trägårdh E, Unterrainer LM, Holzgreve A, Sheikh GT, Rauscher I, Eiber M, Hadaschik BA, Fendler WP; PROMISE Registry Group. Karpinski MJ, et al. Among authors: miederer m. Eur Urol. 2025 Nov;88(5):484-495. doi: 10.1016/j.eururo.2025.04.017. Epub 2025 May 2. Eur Urol. 2025. PMID: 40318933 Free article.
Value of PET imaging for radiation therapy.
Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC; Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN. Lapa C, et al. Among authors: miederer m. Strahlenther Onkol. 2021 Sep;197(9):1-23. doi: 10.1007/s00066-021-01812-2. Epub 2021 Jul 14. Strahlenther Onkol. 2021. PMID: 34259912 Review.
Value of PET imaging for radiation therapy.
Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC; “Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN”. Lapa C, et al. Among authors: miederer m. Nuklearmedizin. 2021 Oct;60(5):326-343. doi: 10.1055/a-1525-7029. Epub 2021 Jul 14. Nuklearmedizin. 2021. PMID: 34261141 Review. English.
87 results